Sam Chun Dang Pharm. Co., Ltd (KOSDAQ: A000250)
Health Care · Pharmaceuticals · KR
₩243,500.00
+17.63% today · +16.5% 1Y
Sam Chun Dang Pharm. Co., Ltd (KOSDAQ: A000250) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $4.24B.
Over the last twelve months the share price has gained 16.5%, trading between 120.00K and 1.23M.
Tweenvest scores Sam Chun Dang Pharm. Co., Ltd across four factors: quality 82/100, value 25/100, dividend 2/100. Its strongest factor is quality.
A000250 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $4.24B
- Revenue (TTM)
- $167.83M
- P/E
- —
- EPS
- 762.42
- Dividend yield
- 0.02%
- Beta (5Y)
- 1.41
- 52-week high
- ₩1,233,000.00
- 52-week low
- ₩120,000.00
- Avg volume (3M)
- —
- Shares outstanding
- 23.41M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Changchun High-Tech Industry (Group) Co., Ltd.SZSE: 000661 | $4.31B | CN¥71.90 | +3.86% |
| Apeloa Pharmaceutical Co.,LtdSZSE: 000739 | $4.27B | CN¥25.40 | -8.44% |
| Aspen Pharmacare Holdings LimitedJSE: APN | $4.25B | R158.26 | -1.09% |
| Edgewise Therapeutics, Inc.NasdaqGS: EWTX | $4.24B | $39.06 | -0.43% |
| SK Biopharmaceuticals Co., Ltd.KOSE: A326030 | $4.23B | ₩72,700.00 | -4.09% |
| Indivior Pharmaceuticals, Inc.NasdaqGS: INDV | $4.23B | $35.83 | +1.07% |
| Yuhan CorporationKOSE: A000100 | $4.06B | ₩73,100.00 | -1.35% |
| J. B. Chemicals & Pharmaceuticals LimitedBSE: 506943 | $4.02B | Rs— | — |
Figures last refreshed Oct 11, 2026.